S&P Futures
5,906.00 -14.00 (-0.24%) Dow Futures
43,332.00 -208.00 (-0.48%) Nasdaq Futures
20,610.25 -23.25 (-0.11%) Russell 2000 Futures
2,305.40 -12.30 (-0.53%) Crude Oil
68.80 -0.36 (-0.52%) Gold
2,639.60 +25.00 (+0.96%)
Sensus Healthcare, Inc. (SRTS)
Pre-Market:
| Previous Close | 7.64 |
| Open | 7.69 |
| Bid | 6.24 x 200 |
| Ask | 8.51 x 100 |
| Day's Range | 7.67 - 8.69 |
| 52 Week Range | 2.05 - 8.69 |
| Volume | |
| Avg. Volume | 150,817 |
| Market Cap | 137.841M |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | 14.75 |
| EPS (TTM) | 0.57 |
| Earnings Date | Feb 06, 2025 - Feb 10, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.25 |
ZacksWall Street Analysts See a 39.66% Upside in Sensus Healthcare (SRTS): Can the Stock Really Move This High?
The mean of analysts' price targets for Sensus Healthcare (SRTS) points to a 39.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
GlobeNewswireREVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer’s request. The agreement with the new customer remains in effect. Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago Expects to have more than 50 IG-SRT Systems signed under the
